Gimme Care Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.5/10
Best for: a flat all-in price at every dose, in every state
Gimme Care scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. It charges from $119 a month, paid up front; its compounded tirzepatide, at $199, is 26% below the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Gimme Care sells compounded semaglutide at $160 a month and compounded tirzepatide at $199, at any dose. Longer billing cycles cut the monthly rate to $130 and $163 on three months, or $119 and $149 on six. There is no membership fee; the consult, drug, supplies and delivery are all in the quoted price. It serves all 50 states plus DC and carries a LegitScript seal.
Is Gimme Care legit?
Yes. Gimme Care is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 8.5/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Gimme Care promo or coupon code?
We know of no promo or coupon code for Gimme Care. Its listed price is $119 a month. Coupon sites advertising "Gimme Care discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Gimme Care compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Gimme Care
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
RxSpan MD
Best for: knowing which pharmacy fills the vial: it names Belmar Pharmacy
Editorial score · methodology
Gimme Care at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $119/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states + DC
- FDA status
- No FDA warning letters found
How Gimme Care scores
Six columns, each one computed from something Gimme Care has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
7.2/10$199/month is 26% below the $269 median for compounded tirzepatide across the sellers we compare. A cheaper plan paid several months up front is also listed.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
8.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states and DC.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Gimme Care
Last checked October 2026- Checked the listed price across 6 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Gimme Care
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Gimme Care involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Gimme Care shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Gimme Care does not require a live video visit before a first prescription.
- 3Ask Gimme Care which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 4The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $119, tirzepatide $149. That leaves out membership fees, first-month rates and insurance copays.
- Gimme Care serves all 50 states and DC.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Cancelling Gimme Care
Taken from the terms Gimme Care publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None on the monthly cycle
- Refund policy
- Full refund if canceled before the pharmacy ships; dispensed medication is final sale
- Early-termination fee
- None
Medications Gimme Care lists
Gimme Care lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Listed under a 3-month billing cycle: "$130 per month with a 3-month plan (billed every 3 months)".
Listed under a 6-month billing cycle at $119 a month; Gimme Care's terms call multi-month plans "prepaid".
Listed under a 3-month billing cycle at $163 a month; Gimme Care's terms call multi-month plans "prepaid".
Listed under a 6-month billing cycle at $149 a month; Gimme Care's terms call multi-month plans "prepaid".
Check the price yourself before you pay
Every figure here comes from Gimme Care's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $160 a month, 20% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $199 a month, 26% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states and DC
- We found no FDA warning letters issued to Gimme Care
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Gimme Care charges
Gimme Care charges $119/month, and holds that rate across every dose. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
- Compounded semaglutide (1-month): $160/month
- Compounded semaglutide (3-month plan): $130/month
- Compounded semaglutide (6-month plan): $119/month
- Compounded tirzepatide (1-month): $199/month
- Compounded tirzepatide (3-month plan): $163/month
- Compounded tirzepatide (6-month plan): $149/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so Gimme Care's $199 is genuinely below the middle, not just advertised that way. Some of Gimme Care's plans are paid several months up front, so read the terms you agree to at checkout before you choose a longer one. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
bmiMD, at about $129/month, is the closest like-for-like alternative we review.
What Gimme Care dispenses
Gimme Care prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
Safety and disclosure
Gimme Care tells you its price before you start the medical questionnaire and that it treats patients in all 50 states. We found no FDA warning letters issued to Gimme Care. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Gimme Care will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Gimme Care bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- you need access wherever you live
Our read
Gimme Care competes on price without an obvious sacrifice elsewhere: $199/month for compounded tirzepatide, no FDA warning letters, and wide state coverage.
The Bottom Line
Gimme Care scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. It charges from $119 a month, paid up front; its compounded tirzepatide, at $199, is 26% below the $269 median among the sellers we compare.
Before you pay Gimme Care
Starting at $119 a month. Check today's price, then start the intake.
Where Gimme Care is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider RxSpan MD.
If none of these fits, our guide to alternatives to Gimme Care sets more sellers in the same category beside Gimme Care on price, states and what the price includes.
Compare Gimme Care head to head
Our head-to-head pages for Gimme Care are Gimme Care vs Trinity Meds, Gimme Care vs PlushCare, Gimme Care vs Brello Health, Gimme Care vs altRX, Gimme Care vs Nurx, and Gimme Care vs Polly.
Frequently Asked Questions
How to check Gimme Care yourself
- How to Verify an Online GLP-1 Pharmacy: Six Public Checks
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- How to Read a Peptide Certificate of Analysis (and What It Cannot Prove)
Every seller that ships to your state, side by side: Georgia, Illinois, North Dakota, Rhode Island, South Carolina, South Dakota, Vermont, Washington and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Gimme Care review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Gimme Care's current pricing
Plans start at $119 a month. Whether you qualify is a clinician's decision, made after your intake.